Callan Family Office’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.69M	Buy	67,038 +47,264	+239%	+$2.6M	0.12%	191
2025 Q1	$1.4M	Buy	19,774 +12,304	+165%	+$870K	0.1%	168
2024 Q4	$491K	Buy	+7,470	New	+$491K	0.03%	372
2023 Q2	–	Sell	-5,000	Closed	-$486K	–	114
2023 Q1	$486K	Buy	+5,000	New	+$486K	0.12%	93